Medication info
Clotex Tablets (Clopidogrel Sulfate)

Clotex Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201903699 · Approved 2019.06.03 · Insurance code 057600050

Summary

Main use
Improvement of atherosclerotic symptoms, treatment of acute coronary syndrome, prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg must be coadministered with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg must be coadministered with this medicine once daily. Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and bleeding diathesis is limited. This medicine may be administered regardless of food intake.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Improvement of atherosclerotic symptoms, treatment of acute coronary syndrome, prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q myocardial infarction
  • cardiovascular events
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms related to atherosclerosis, such as ischemic stroke, myocardial infarction, and peripheral artery disease. It also helps to reduce the risk of death or recurrence related to cardiovascular events in patients with acute coronary syndrome, such as unstable angina or non-Q myocardial infarction who have undergone coronary interventional procedures or surgery. In patients with atrial fibrillation who have vascular risk factors and for whom vitamin K antagonists are not appropriate, this medication lowers the risk of stroke and thrombosis, thus improving health. This drug prevents complications from various vascular diseases effectively protecting the patients' cardiovascular health and improving symptoms.

How to take

Adult dose

Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg must be coadministered with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg must be coadministered with this medicine once daily. Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and bleeding diathesis is limited. This medicine may be administered regardless of food intake.

Precautions

This medication prevents platelets from aggregating and avoids excessive blood clotting. The efficacy of this medication may be diminished in individuals genetically predisposed to decreased function of a specific enzyme (CYP2C19), so in such cases, treatment methods should be adjusted in consultation with a doctor. Additionally, taking this medication with drugs that activate certain enzymes may increase drug concentration and elevate bleeding risk, so caution is necessary. Individuals allergic to this medication or its components, those with bleeding tendencies, those with severe liver damage, nursing mothers, and those with lactose intolerance should not take this medication. Patients who are at risk of bleeding or those who are scheduled for surgery should carefully monitor for signs of bleeding while taking this medication and may need to have blood tests if necessary. Particularly, taking this medication together with other antiplatelet or anticoagulant drugs, non-steroidal anti-inflammatory drugs (NSAIDs), and selective serotonin reuptake inhibitors (SSRIs) may increase the risk of bleeding and should be done with caution. This medication may prolong bleeding time, which means that even minor wounds may bleed for a longer duration, so if bleeding does not stop or is severe, immediate consultation with a doctor is required. While taking this medication, side effects such as headache, dizziness, dyspepsia, diarrhea, skin rashes, and others may occur, and in rare cases, blood disorders or serious bleeding may arise. If symptoms of infection (e.g., fever) develop during this medication course, prompt notification to a doctor and testing is necessary. During pregnancy, the risks to the fetus are low, but due to the possibility of bleeding during delivery, it is advisable to discontinue this medication about 5 to 7 days before the expected delivery date. Nursing mothers should consult with their doctor regarding whether to continue breastfeeding as this medication may be excreted in breast milk. Elderly patients and those with impaired kidney or liver functions may be at a higher risk of bleeding and should take this medication with caution. Excessive dosing may increase the risk of bleeding, and currently, there is no antidote for this medication; thus, severe bleeding may need treatment such as platelet transfusion. This medication should be kept out of reach of children and should not be transferred to another container for safety.

Side effects

  • Hemorrhage
  • gastrointestinal hemorrhage
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 111 more
  • hemorrhagic stroke
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • nausea
  • depression
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • syncope
  • palpitations
  • weakness
  • fever
  • hernia
  • heart failure
  • atrial fibrillation
  • leg cramps
  • sensory loss
  • neuralgia
  • sensory disturbance
  • vertigo
  • constipation
  • vomiting
  • increased liver enzymes
  • gout
  • hyperuricemia
  • arthralgia
  • low back pain
  • anxiety
  • insomnia
  • anemia
  • pneumonia
  • sinusitis
  • eczema
  • skin ulcer
  • cystitis
  • cataract
  • conjunctivitis
  • reduced motor function
  • tremor
  • speech disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • sensory anomaly
  • insomnia
  • depression
  • memory loss
  • disturbance of consciousness
  • abnormal behavior
  • arthritis
  • gynecomastia
  • elevated prostate-specific antigen
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • purpuric rash
  • erythematous skin rash
  • urticaria
  • itching
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • lichen planus
  • glomerulonephritis
  • fever
  • abnormal liver function tests
  • increased serum creatinine
  • cholecystitis
  • hematemesis
  • spinal hematoma
  • Kounis syndrome
  • anaphylaxis-like reaction
  • serum sickness
  • confusion
  • hallucination
  • taste disturbance
  • taste loss
  • hemothorax
  • herpes zoster
  • erythematous lesions
  • purpuric rash
  • urticaria
  • renal dysfunction
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for an extended period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.